5 Transplant recipients post-transplant
5.1 Ensure that patients are managed in strict protective isolation. Assess the need for any procedures outside of isolation against the risk of exposing the patient to COVID‑19.
5.2 Tell patients who have had haematopoietic stem cell transplantation (HSCT) to follow the professional advice from their clinical team on how best to minimise their risk of respiratory infections (including COVID-19). Guidance for clinicians and patients to support risk assessments is available on the BSBMTCT website. [amended 29 July 2020]
5.3 Isolate patients who have tested positive for COVID‑19 in negative pressure cubicles, or neutral pressure cubicles if this is not possible.